The availability of a novel predictive biomarker in diabetes care could have benefits for patients, payers, and pharma.
Ralph McDade, PhD
Advertisement
Articles by Ralph McDade, PhD
Advertisement
Latest Updated Articles
- Evidence for the Benefit of Targeted Proteomics in the Era of the "Big Data" Approach
Published: March 18th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
5
